Apellis Pharmaceuticals (APLS) Change in Inventory (2021 - 2025)
Historic Change in Inventory for Apellis Pharmaceuticals (APLS) over the last 5 years, with Q3 2025 value amounting to -$5.4 million.
- Apellis Pharmaceuticals' Change in Inventory rose 3758.52% to -$5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.4 million, marking a year-over-year decrease of 10497.43%. This contributed to the annual value of $10.8 million for FY2024, which is 8226.62% down from last year.
- According to the latest figures from Q3 2025, Apellis Pharmaceuticals' Change in Inventory is -$5.4 million, which was up 3758.52% from $26.0 million recorded in Q2 2025.
- In the past 5 years, Apellis Pharmaceuticals' Change in Inventory ranged from a high of $47.8 million in Q4 2023 and a low of -$14.0 million during Q1 2025
- Moreover, its 5-year median value for Change in Inventory was $14.5 million (2024), whereas its average is $9.4 million.
- Per our database at Business Quant, Apellis Pharmaceuticals' Change in Inventory surged by 1046180.56% in 2024 and then crashed by 19380.74% in 2025.
- Over the past 5 years, Apellis Pharmaceuticals' Change in Inventory (Quarter) stood at $14.6 million in 2021, then soared by 77.33% to $26.0 million in 2022, then surged by 84.18% to $47.8 million in 2023, then crashed by 120.96% to -$10.0 million in 2024, then soared by 46.09% to -$5.4 million in 2025.
- Its last three reported values are -$5.4 million in Q3 2025, $26.0 million for Q2 2025, and -$14.0 million during Q1 2025.